A manifesto for clinical pharmacology from principles to practice.

British Journal of Clinical Pharmacology
Jeffrey K Aronson

Abstract

1. This is a manifesto for UK clinical pharmacology. 2. A clinical pharmacologist is a medically qualified practitioner who teaches, does research, frames policy, and gives information and advice about the actions and proper uses of medicines in humans and implements that knowledge in clinical practice. Those without medical qualifications who practise some aspect of clinical pharmacology could be described as, say, 'applied pharmacologists'. 3. Clinical pharmacology is operationally defined as a translational discipline in terms of the basic tools of human pharmacology (e.g. receptor pharmacology) and applied pharmacology (e.g. pharmacokinetics) and how they are used in drug discovery and development and in solving practical therapeutic problems in individuals and populations. 4. Clinical pharmacologists are employed by universities, health-care services, private organizations (such as drug companies), and regulatory agencies. They are mentors and teachers, teaching laboratory science, clinical science, and all aspects of practical drug therapy as underpinned by the science of pharmacology; they write and edit didactic and reference texts; researchers, covering research described by the operational definition; clinicians, prac...Continue Reading

References

Apr 9, 1976·Science·J H Comroe, R D Dripps
Nov 28, 1987·British Medical Journal·R Smith
Aug 29, 1970·Lancet·J Parkhouse
Jan 1, 1994·Fundamental & Clinical Pharmacology·J L MontastrucJ M Senard
Jul 1, 1993·British Journal of Clinical Pharmacology·T Walley
Jun 20, 2003·British Journal of Clinical Pharmacology·Simon MaxwellUNKNOWN BPS Clinical Section Committee
Sep 13, 2003·BMJ : British Medical Journal·Nicholas J Wald, Joan K Morris
Nov 25, 2003·BMJ : British Medical Journal·J K Aronson, R E Ferner
Sep 27, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jeffrey K Aronson, Robin E Ferner
Sep 7, 2006·JAMA : the Journal of the American Medical Association·Dario SambunjakAna Marusić
Oct 26, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Robin E Ferner, Jeffrey K Aronson
Nov 23, 2006·British Journal of Clinical Pharmacology·J K Aronson
Jul 15, 2009·British Journal of Clinical Pharmacology·Jeffrey K Aronson
Jul 15, 2009·British Journal of Clinical Pharmacology·Robert Likic, Simon R J Maxwell
Sep 8, 2009·Expert Review of Molecular Diagnostics·Jerzy Ostrowski, Lucjan S Wyrwicz
Oct 2, 2009·Current Genomics·Edward R Dougherty
Dec 17, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Robin E Ferner, Jeffrey K Aronson
Dec 17, 2009·JAMA : the Journal of the American Medical Association·Dario Sambunjak, Ana Marusić
Mar 18, 2010·British Journal of Clinical Pharmacology·Jeffrey K Aronson
Apr 1, 2005·Drug Discovery Today. Technologies·Henderik W Frijlink, Anne H de Boer

❮ Previous
Next ❯

Citations

Dec 20, 2012·European Journal of Clinical Pharmacology·Susanna M WallerstedtSven Wallerstedt
May 10, 2013·European Journal of Clinical Pharmacology·Susanna M Wallerstedt, Staffan Rosenborg
Jul 4, 2013·European Journal of Clinical Pharmacology·Jeffrey K Aronson, Giampaolo Velo
May 28, 2014·Nursing Outlook·Mitchell R KniselyDiane Von Ah
Oct 16, 2015·British Journal of Clinical Pharmacology·Jennifer H MartinMatthias Schwab
Mar 1, 2012·British Journal of Clinical Pharmacology·Jeffrey K Aronson
Mar 1, 2012·British Journal of Clinical Pharmacology·A Richard Green, Jeffrey K Aronson
Sep 7, 2012·British Journal of Clinical Pharmacology·Jeffrey K Aronson
Dec 24, 2010·British Journal of Clinical Pharmacology·Clive Page
Jul 21, 2010·British Journal of Clinical Pharmacology·A SomogyiJ M Ritter
Feb 3, 2011·British Journal of Clinical Pharmacology·J Desmond Fitzgerald
Apr 13, 2011·British Journal of Clinical Pharmacology·Geoffrey T Tucker, John O Miners
Apr 27, 2016·Indian Journal of Pharmacology·Ashwin Kamath
Aug 13, 2011·British Journal of Clinical Pharmacology·Jeffrey K Aronson
May 5, 2012·British Journal of Clinical Pharmacology·David Williams
Feb 26, 2014·Current Opinion in Pharmacology·David G TristAlan Bye
Jun 28, 2017·British Journal of Clinical Pharmacology·Serge Cremers, Jeffrey K Aronson
Dec 5, 2018·Expert Review of Clinical Pharmacology·Giovanni Di PerriStefano Bonora
Jan 1, 2016·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Janica Chavda, Anika Patel
Jan 21, 2020·Clinical Pharmacology and Therapeutics·Alex ZhavoronkovTudor I Oprea
Dec 22, 2015·Pharmacy : Journal of Pharmacy, Education and Practice·Anna Birna Almarsdottir, Anne Gerd Granas
Jan 21, 2020·Medical Science Educator·Madeleine E NorrisCharys M Martin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Journal of Clinical Pharmacology
Jeffrey K Aronson
British Journal of Clinical Pharmacology
Michael D Rawlins
British Journal of Clinical Pharmacology
Julia C Buckingham
© 2021 Meta ULC. All rights reserved